REAL Form 4: Director Gains 26,025 Shares via RSU Grant
TheRealReal, Inc. (REAL) – Form 4 insider filing Director Caretha Coleman reported the grant of 26,025 deferred restricted stock units (DRSUs) on 07/23/2025.
Rhea-AI Filing Summary
TheRealReal, Inc. (REAL) – Form 4 insider filing
Director Caretha Coleman reported the grant of 26,025 deferred restricted stock units (DRSUs) on 07/23/2025. Each DRSU converts into one share of REAL common stock upon settlement; the grant carried a stated price of $0, indicating an equity-based compensation award rather than an open-market purchase. Following the award, Coleman's direct beneficial ownership rises to 251,783 shares, further aligning the director’s economic interest with shareholders. No derivative securities were involved and no dispositions were reported.
The filing is routine compensation-related and does not include any earnings data or guidance. While the additional shares modestly increase insider ownership, the absence of cash consideration or open-market buying means the signal for outside investors is limited.
Positive
- Director’s ownership increases by 26,025 shares, slightly enhancing board-shareholder alignment.
Negative
- Grant is compensation-based at $0 cost, so it provides limited insight into the director’s market conviction or REAL’s valuation.
Insights
TL;DR: Routine equity grant; modestly raises insider stake, neutral fundamental impact.
The award adds ~26k shares to a director’s holdings, lifting total ownership to roughly 0.25 million shares. Because the shares stem from deferred RSUs issued at no cost, the transaction reflects standard board compensation, not a discretionary purchase that might indicate management’s valuation view. Consequently, the filing offers little insight into REAL’s near-term performance or valuation trajectory. Market impact should be minimal, though incremental alignment with shareholders can be viewed as a small positive for governance.
TL;DR: Governance-neutral event; standard board compensation structure.
Deferred RSU grants are customary for non-employee directors among NASDAQ-listed firms. The settlement feature defers tax liability and fosters longer-term ownership. Coleman's increased stake marginally strengthens board-shareholder alignment but does not alter control dynamics. No red flags or unusual structures appear; thus, the event is governance-neutral and not expected to influence investor sentiment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 26,025 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Coleman's total beneficial ownership in TheRealReal (REAL) after the transaction?
Was the acquisition an open-market purchase or a stock grant?
Is the filing likely to affect TheRealReal’s stock price?
AI-generated analysis. How Rhea-AI works. Not financial advice.